CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Jul. 31, 2020	Jul. 31, 2019
Operating activities
Net income	$ 352	$ 76,165
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	115,274	97,829
Amortization of share-based compensation	7,500	9,661
Live inventory adjustment (net of prior period reversal)	(2,800)	(9,600)
Provision for losses (recoveries) on accounts receivable	0	(2,000)
Deferred income taxes	61,155	21,000
Gain (Loss) on Disposition of Assets	328	0
Change in assets and liabilities:
Accounts receivable - trade	(18,995)	(8,294)
Accounts receivable - insurance	445	1,494
Income taxes	(34,635)	25,719
Inventories	6,787	(56,590)
Prepaid expenses and other assets	(8,955)	(17,729)
Right of use assets	12,173	0
Lease liabilities	(12,173)	0
Accounts payable	(23,021)	5,330
Accrued expenses and other liabilities	12,285	9,099
Total adjustments	115,368	75,919
Net cash provided by operating activities	115,720	152,084
Investing activities
Capital expenditures	(165,998)	(210,878)
Net proceeds from sale of property and equipment	336	1,535
Net cash used in investing activities	(165,662)	(209,343)
Financing activities
Payment of debt issuance costs	0	(2,225)
Borrowings from revolving line of credit	145,000	100,000
Payments on revolving line of credit	(105,000)	(70,000)
Proceeds from issuance of restricted stock under stock compensation plans	879	708
Payments from issuance of common stock under stock compensation plans	(6,005)	(3,976)
Dividends paid	(14,230)	(14,179)
Net cash provided by financing activities	20,644	10,328
Net change in cash and cash equivalents	(29,298)	(46,931)
Cash and cash equivalents at beginning of period	95,417	121,193
Cash and cash equivalents at end of period	66,119	74,262
Supplemental disclosure of non-cash investing and financing activities:
Capital expenditures included in accounts payable	3,242	5,659
Dividends payable	$ 7,117	$ 7,089